See more : Ollie’s Bargain Outlet Holdings, Inc. (OLLI) Income Statement Analysis – Financial Results
Complete financial analysis of Quick-Med Technologies, Inc. (QMDT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Quick-Med Technologies, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Hiro Metaverse Acquisitions I S.A. (HMA1.L) Income Statement Analysis – Financial Results
- BK Brasil Operação e Assessoria a Restaurantes S.A. (BKBR3.SA) Income Statement Analysis – Financial Results
- State Grid Yingda Co.,Ltd. (600517.SS) Income Statement Analysis – Financial Results
- Atalaya Mining Plc (ATYM.L) Income Statement Analysis – Financial Results
- Mr.Bricolage S.A. (ALMRB.PA) Income Statement Analysis – Financial Results
Quick-Med Technologies, Inc. (QMDT)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.quickmedtech.com
About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc., a life sciences company, focuses on developing and commercializing proprietary broad-based technologies in medical and consumer healthcare markets. It specializes in the research and development of biomedical products and devices for antibacterial applications. The company's core technologies include Novel Intrinsically Micro-Bonded Utility Substrate (NIMBUS), a family of advanced polymers with antimicrobial, hemostatic, and other properties for use in a range of applications; Stay Fresh, a chemical formulation for textiles with a durable antimicrobial agent effective against an array of bacteria; and MultiStat, a family of advanced patented methods and compounds effective in skin therapy applications. It serves government agencies; and healthcare and medical, apparel and textile, and personal care companies. The company was founded in 1997 and is headquartered in Gainesville, Florida.
| Metric | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 928.49K | 997.50K | 1.04M | 993.94K | 1.00M | 1.36M | 1.95M | 1.23M | 181.72K | 48.00K | 0.00 | 0.00 |
| Cost of Revenue | 280.51K | 325.88K | 347.37K | 284.91K | 259.35K | 56.16K | 277.83K | 187.16K | 27.75K | 0.00 | 0.00 | 0.00 |
| Gross Profit | 647.99K | 671.62K | 692.21K | 709.04K | 745.38K | 1.30M | 1.67M | 1.04M | 153.98K | 48.00K | 0.00 | 0.00 |
| Gross Profit Ratio | 69.79% | 67.33% | 66.59% | 71.34% | 74.19% | 95.87% | 85.77% | 84.79% | 84.73% | 100.00% | 0.00% | 0.00% |
| Research & Development | 519.84K | 847.35K | 1.02M | 1.22M | 1.06M | 1.56M | 1.53M | 865.39K | 579.03K | 348.45K | 618.08K | 120.66K |
| General & Administrative | 467.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 466.74K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 467.20K | 998.39K | 1.65M | 1.50M | 1.38M | 1.90M | 1.66M | 1.76M | 1.38M | 1.93M | 2.57M | 734.61K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.02M | 1.91M | 2.74M | 2.79M | 2.51M | 3.53M | 3.25M | 2.68M | 2.01M | 2.32M | 3.22M | 875.79K |
| Cost & Expenses | 1.30M | 2.24M | 3.09M | 3.08M | 2.77M | 3.59M | 3.53M | 2.87M | 2.04M | 2.32M | 3.22M | 875.79K |
| Interest Income | 7.65K | 1.38K | 2.13K | 2.02K | 2.29K | 2.20K | 935.00 | 11.64K | 9.71K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 446.19K | 449.96K | 449.14K | 1.47M | 259.87K | 167.42K | 96.37K | 76.01K | 100.87K | 93.04K | 0.00 | 28.04K |
| Depreciation & Amortization | 37.02K | 64.20K | 68.36K | 70.61K | 71.91K | 72.54K | 61.82K | 50.02K | 45.52K | 44.36K | 39.77K | 20.53K |
| EBITDA | -229.86K | -1.17M | -1.79M | -2.01M | -1.69M | -2.15M | -1.52M | -1.59M | -1.81M | -2.23M | -3.18M | -855.27K |
| EBITDA Ratio | -35.69% | -117.57% | -190.59% | -202.46% | -168.29% | -158.14% | -86.12% | -128.95% | -1,004.62% | -4,648.16% | 0.00% | 0.00% |
| Operating Income | -376.08K | -1.24M | -2.05M | -2.08M | -1.77M | -2.22M | -1.58M | -1.64M | -1.85M | -2.28M | -3.22M | -875.79K |
| Operating Income Ratio | -40.50% | -124.14% | -197.37% | -209.77% | -175.67% | -163.47% | -80.76% | -133.02% | -1,020.05% | -4,740.57% | 0.00% | 0.00% |
| Total Other Income/Expenses | -337.00K | -448.58K | -251.43K | -1.47M | -257.58K | -165.23K | 71.07K | -64.37K | -73.68K | -93.04K | -1.04M | -28.04K |
| Income Before Tax | -713.07K | -1.69M | -2.30M | -3.55M | -2.02M | -2.39M | -1.51M | -1.70M | -1.93M | -2.37M | -4.26M | -903.83K |
| Income Before Tax Ratio | -76.80% | -169.11% | -221.55% | -357.18% | -201.31% | -175.61% | -77.12% | -138.25% | -1,060.59% | -4,934.40% | 0.00% | 0.00% |
| Income Tax Expense | 446.19K | 1.38K | 449.14K | 2.02K | 2.29K | 0.00 | -71.07K | 0.00 | 73.68K | 0.00 | 0.00 | 0.00 |
| Net Income | -713.07K | -1.69M | -2.30M | -3.55M | -2.02M | -2.39M | -1.51M | -1.70M | -1.93M | -2.37M | -4.26M | -903.83K |
| Net Income Ratio | -76.80% | -169.11% | -221.55% | -357.18% | -201.31% | -175.61% | -77.12% | -138.25% | -1,060.59% | -4,934.40% | 0.00% | 0.00% |
| EPS | -19.09 | -0.05 | -0.07 | -0.11 | -0.07 | -0.08 | -0.05 | -0.06 | -0.08 | -0.14 | -0.32 | -0.07 |
| EPS Diluted | -19.09 | -0.05 | -0.07 | -0.11 | -0.07 | -0.08 | -0.05 | -0.06 | -0.08 | -0.14 | -0.32 | -0.07 |
| Weighted Avg Shares Out | 37.35K | 37.35M | 32.95M | 31.26M | 30.94M | 30.72M | 30.36M | 30.08M | 23.27M | 16.41M | 13.29M | 12.12M |
| Weighted Avg Shares Out (Dil) | 37.35K | 37.35M | 32.95M | 31.26M | 30.94M | 30.72M | 30.36M | 30.08M | 23.27M | 16.41M | 13.29M | 12.12M |
Source: https://incomestatements.info
Category: Stock Reports